• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Predictive Genetic Testing and Consumer Wellness Genomics Market Analysis

    ID: MRFR/LS/9360-HCR
    120 Pages
    Rahul Gotadki
    October 2025

    Predictive Genetic Testing & Consumer/Wellness Genomics Market Research Report Information by Test Type (Predictive Testing [Genetic Susceptibility Test, Predictive Diagnostic, and Population Screening], Consumer Genomics, and Wellness Genomics [Nutria Genetic, Skin & Metabolism Genetics, and Others], by Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screen...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    ReportInfographic
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Market Analysis

    In-depth Analysis of Predictive Genetic Testing and Consumer Wellness Genomics Market Industry Landscape

    Due to genomic technologies, public awareness, and a desire for individualized treatment, predictive genetic testing and consumer wellness genomics are increasing rapidly. These marketplaces provide genetic testing that reveal a person's lifestyle, illness propensity, and general health. Rising consumer knowledge and participation in genetics drives market dynamics. A consumer-driven industry for predictive genetic testing and wellness genomics has grown as people seek proactive health solutions. Direct-to-consumer genetic testing is growing. DTC services enable consumers to get genetic information without healthcare practitioner participation, increasing accessibility, convenience, and market growth. Disease risk is the main focus of predictive genetic testing. The growth of genetic test disease indicators, from common ailments like cardiovascular disease to uncommon genetic abnormalities, provides consumers with complete health information and shapes market dynamics. Market dynamics depend on genome sequencing advances. Due to lower sequencing costs, increased accuracy, and efficiency, genetic testing is now more accessible to a broader audience, driving market expansion. The predictive genetic testing and wellness genomics industry is affected by AI and data analytics. These technologies improve genetic data interpretation, enabling more nuanced and individualized disease risk, nutritional, and lifestyle insights and commercial innovation. Regulations and genetic privacy concerns affect market dynamics. To earn customer confidence and comply with changing regulatory norms, market actors are installing stronger privacy protections to assure ethical genetic data usage. Lifestyle optimization is part of consumer wellness genomics beyond illness risk assessment. Genetic testing that provides insights into diet, exercise, sleep habits, and other lifestyle aspects is becoming more popular, allowing people to make healthy decisions. Healthcare provider-genetic testing company partnerships are influencing the industry. These collaborations incorporate genetic information into the healthcare ecosystem to provide tailored and preventative treatment and increase clinical genetic testing. Predictive genetic testing and consumer wellness genomics markets are global. As awareness and technology improve, the worldwide market expands. Market dynamics are diversifying as emerging economies shine. Educational attempts to improve genetic literacy affect the market. Genetic counseling services are increasingly essential to the market, providing full genetic test findings and enabling informed decision-making. Looking forward, the predictive genetic testing and consumer wellness genomics business is positioned for continuous innovation. Genetic data integration with digital health platforms, testing panel extension, and genomic interpretation of non-coding areas may be future developments. As these markets evolve, technology advances, legislative changes, and genomics' inclusion into mainstream healthcare and lifestyle practices will affect the dynamics.

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

    The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

    Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

    North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

    What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

    High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

    Market Summary

    Key Market Trends & Highlights

    Market Trends

    Predictive Genetic Testing and Consumer Wellness Genomics Market Market Drivers

    Market Segment Insights

    Regional Insights

    Industry Developments

      • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics
      • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
      • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
      • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
      • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.

    Market Segmentation

    Europe

    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    Asia-Pacific

    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    By Test Type

    • Predictive Testing
    • Consumer Genomics
    • Wellness Genomics

    North America

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    By Setting Type

    • Proteomic Testing
    • Metabolic Testing
    • Genomic Testing

    Rest of the World

    • Middle East
    • Africa
    • Latin America 

    By Application type

    • Breast & Ovarian Cancer
    • Cardiovascular Screening
    • Colon Cancer
    • Others

    List of companies covered in this report:

    • 23andMe, Inc. (California)
    • Myriad Genetics, Inc. (US)
    • Hoffmann-La Roche Ltd. (Switzerland)
    • Abbott Laboratories (US)
    • Genesis Genetics (US)
    • Agilent Technologies (US)
    • Thermo Fisher Scientific, Inc. (US)
    • Bureau Gravimétrique International (China)
    • Bio-Rad Laboratories Inc. (US)
    • Illumina, Inc. (US)
    • Counsyl, Inc. (California)
    • ARUP Laboratories  (US)
    • Others

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Region

    • US
    • Canada
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Middle East
    • Africa
    • Latin America 

    Predictive Genetic Testing & Consumer/Wellness Genomics Recent Developments

    • In June 2019, Thermo Fisher Scientific Inc. (US) entered into a global research collaboration with predictive laboratories to concentrate on women's infertility via genetic factors. It is taking advantage of the market's apex.
    • In February 2020, Bureau Gravimétrique International (China) signed an agreement with giant distributors in Brazil, Argentina, Peru, Ecuador, Colombia, and Mexico. The partnership paves the way for the company to extend its DNA sequencing and laboratory automation offerings in Latin America.
    • In July 2020, 23andMe, Inc (California) collaborated with the giant GlaxoSmithKline (UK) to provide a genetic database of approximately ten million populations searching for cancer information. This added value and further fuels the growth of the predictive genetic testing & consumer/wellness genomics
    • In August 2020, Thermo Fischer Scientific introduced an Oncomine Myeloid Assay GX that enables users to identify biomarkers associated with myeloproliferative neoplasm by detecting over 600 fusion isotypes. This product has contributed to the market's expansion.
    • In June 2021, Bio-Rad Laboratories, Inc. (US), Bioaster (France), and Genetic Analysis (Norway) partnered to provide genetic metabolic disorders on the microbiome. This augments the growth of the predictive genetic testing & consumer/wellness genomics

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Test Type

    • Wellness Genomics
    • Nutria Genetic
    • Skin & Metabolism Genetics
    • Others
    • Consumer Genomics
    • Predictive Testing
    • Genetic Susceptibility Test
    • Predictive Diagnostic
    • Population Screening

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Application

    • Breast & Ovarian Cancer
    • Cardiovascular Screening
    • Diabetic Screening & Monitoring
    • Colon Cancer
    • Parkinsonism/Alzheimer’s Disease
    • Urologic Screening/Prostate Cancer Screening
    • Orthopedic & Musculoskeletal
    • Others

    Predictive Genetic Testing & Consumer/Wellness Genomics Market, by Setting Type

    • Proteomic Testing
    • Metabolic Testing
    • Genomic Testing

    Report Scope

    Report Attribute/Metric Details
      Market Size   USD 11.2 Billion
      CAGR   5.4%
      Base Year   2022
      Forecast Period   2023-2032
      Historical Data   2021
      Forecast Units   Value (USD Billion)
      Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Test Type, Application, and Setting Type
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World
      Key Vendors   23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US)
      Key Market Opportunities   Rise of application in personalized medicine
      Key Market Drivers   Usage of predictive genetic testing & consumer/wellness genomics in various applications

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM

    FAQs

    How Big is the Predictive Genetic Testing & Consumer/Wellness Genomics market?

    The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 5.4 billion by 2032 at 11.2% CAGR during the forecast period (2023 - 2032)

    Who are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    23andMe, Inc. (California), Myriad Genetics, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Genesis Genetics (US), Agilent Technologies (US), Thermo Fisher Scientific, Inc. (US), Bureau Gravimétrique International (China), Bio-Rad Laboratories Inc. (US), Illumina, Inc. (US), Counsyl, Inc. (California), ARUP Laboratories (US) are the key competitors in the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which region is predicted to have the largest market share of Predictive Genetic Testing & Consumer/Wellness Genomics?

    North America holds the largest share in the global market of Predictive Genetic Testing & Consumer/Wellness Genomics

    What are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics?

    Usage of predictive genetic testing & consumer/wellness genomics in various applications and Rising R&D initiatives for novel therapeutics are the key factors driving the market of Predictive Genetic Testing & Consumer/Wellness Genomics.

    Which factors may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics?

    High cost of genomic research instruments and Inadequate funding and lack of trained professionals may act as market deterrents Predictive Genetic Testing & Consumer/Wellness Genomics

    1. EXECUTIVE SUMMARY
    2. MARKET INTRODUCTION
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    3. RESEARCH METHODOLOGY
      1. 3.1.
      2. Overview
      3. Data Mining
      4. Secondary Research
      5. Primary Research
        1. Primary Interviews and Information Gathering Process
        2. Breakdown
      6. of Primary Respondents
      7. Forecasting Application
      8. Market Size Estimation
        1. Bottom-Up Approach
        2. Top-Down Approach
      9. Data Triangulation
      10. Validation
    4. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    5. MARKET FACTOR ANALYSIS
      1. 5.1.
      2. Porter’s Five Forces Analysis
      3. 5.1.4.
      4. Threat of Substitutes
      5. on Supply Chain
    6. Bargaining Power of Suppliers
    7. Bargaining Power of Buyers
    8. Threat of New Entrants
    9. Intensity of Rivalry
      1. Value Chain Analysis
      2. COVID-19 Impact Analysis
        1. Market Impact Analysis
        2. Impact
        3. Regional Impact
        4. Opportunity and Threat Analysis
    10. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. BY TEST TYPE
      2. Overview
      3. Predictive Testing
        1. Genetic
        2. Predictive Diagnostic
        3. Population Screening
      4. Susceptibility Test
      5. Consumer Genomics
      6. Wellness Genomics
        1. Nutria Genetic
        2. Skin & Metabolism Genetics
        3. Others
    11. GLOBAL PREDICTIVE
    12. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION
      1. 7.1.
      2. Overview
      3. Breast & Ovarian Cancer
      4. Cardiovascular Screening
      5. Diabetic Screening & Monitoring
      6. Colon Cancer
      7. Parkinsonism/Alzheimer’s
      8. Disease
      9. Urologic Screening/Prostate Cancer Screening
      10. Orthopedic
      11. & Musculoskeletal
      12. Others
    13. GLOBAL PREDICTIVE GENETIC TESTING
    14. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE
      1. Overview
      2. 8.2.
      3. Proteomic Testing
      4. Metabolic Testing
      5. Genomic Testing
      6. 9.
    15. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY REGION
      1. Overview
      2. North America
        1. US
        2. Canada
        3. Germany
        4. France
        5. UK
        6. Italy
        7. Spain
        8. Rest of Europe
      3. 9.2.
      4. Europe
      5. Asia-Pacific
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
      6. Rest of the World
        1. Middle East
        2. Africa
        3. Latin America
    16. COMPANY LANDSCAPE
      1. 10.1.
      2. Overview
      3. Competitive Analysis
      4. Market Share Analysis
      5. 10.4.
      6. Major Growth Strategy in the Global Predictive Genetic Testing & Consumer/Wellness
      7. Genomics Market
      8. Competitive Benchmarking
      9. Leading Players in
      10. Terms of Number of Developments in the Global Predictive Genetic Testing & Consumer/Wellness
      11. Genomics Market
      12. Key developments and Growth Strategies
        1. New
        2. Merger & Acquisitions
      13. Product Launch/Service Deployment
      14. 10.7.3.
      15. Joint Ventures
      16. Major Players
        1. Sales & Operating Income,
        2. Major Players R&D Expenditure. 2020
    17. COMPANY PROFILES
      1. 23andMe, Inc.
        1. Company Overview
        2. Financial Overview
        3. Products Offered
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. Myriad Genetics, Inc.
      3. F.Hoffmann-La
      4. Roche Ltd.
      5. Abbott Laboratories
      6. Genesis Genetics
      7. 11.6.
      8. Agilent Technologies
      9. Thermo Fisher Scientific, Inc.
      10. Bureau
      11. Gravimétrique International
      12. Bio-Rad Laboratories Inc.
      13. 11.10.
      14. Illumina, Inc.
      15. Counsyl, Inc.
      16. ARUP Laboratories
      17. 11.13.
      18. Others
    18. APPENDIX
      1. References
      2. Related Reports
      3. LIST
    19. OF TABLES
    20. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
      1. GENOMICS MARKET SYNOPSIS, 2023–2032
    21. GLOBAL PREDICTIVE GENETIC
      1. TESTING & CONSUMER/WELLNESS GENOMICS MARKET ESTIMATES & FORECAST, 2023–2032
      2. (USD MILLION)
    22. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    23. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    24. GLOBAL
    25. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    26. GLOBAL PREDICTIVE GENETIC TESTING &
    27. CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    28. NORTH AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
    29. MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    30. NORTH AMERICA:
    31. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    32. NORTH AMERICA: PREDICTIVE GENETIC TESTING
    33. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    34. US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. BY TEST TYPE, 2023–2032 (USD MILLION)
    35. US: PREDICTIVE GENETIC
    36. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
      1. (USD MILLION)
    37. US: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    38. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    39. CANADA:
    40. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
    41. CANADA: PREDICTIVE GENETIC TESTING &
    42. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    43. CANADA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. BY SETTING TYPE, 2023–2032 (USD MILLION)
    44. EUROPE: PREDICTIVE
    45. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032
      1. (USD MILLION)
    46. EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    47. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    48. EUROPE:
    49. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
    50. GERMANY: PREDICTIVE GENETIC TESTING &
    51. CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    52. GERMANY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. BY APPLICATION, 2023–2032 (USD MILLION)
    53. GERMANY: PREDICTIVE GENETIC
    54. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
      1. (USD MILLION)
    55. FRANCE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    56. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    57. FRANCE:
    58. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    59. FRANCE: PREDICTIVE GENETIC TESTING &
    60. CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    61. ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. BY TEST TYPE, 2023–2032 (USD MILLION)
    62. ITALY: PREDICTIVE GENETIC
    63. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
      1. (USD MILLION)
    64. ITALY: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    65. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    66. SPAIN:
    67. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
    68. SPAIN: PREDICTIVE GENETIC TESTING &
    69. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    70. SPAIN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. BY SETTING TYPE, 2023–2032 (USD MILLION)
    71. UK: PREDICTIVE GENETIC
    72. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
      1. MILLION)
    73. UK: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
    74. MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    75. UK: PREDICTIVE
    76. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
      1. (USD MILLION)
    77. REST OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    78. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    79. REST
      1. OF EUROPE: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY
      2. APPLICATION, 2023–2032 (USD MILLION)
    80. REST OF EUROPE: PREDICTIVE
    81. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
      1. (USD MILLION)
    82. ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    83. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    84. ASIA-PACIFIC:
    85. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    86. ASIA-PACIFIC: PREDICTIVE GENETIC TESTING
    87. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    88. JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. BY TEST TYPE, 2023–2032 (USD MILLION)
    89. JAPAN: PREDICTIVE GENETIC
    90. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032
      1. (USD MILLION)
    91. JAPAN: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    92. GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    93. CHINA:
    94. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE,
    95. CHINA: PREDICTIVE GENETIC TESTING &
    96. CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    97. CHINA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. BY SETTING TYPE, 2023–2032 (USD MILLION)
    98. INDIA: PREDICTIVE GENETIC
    99. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
      1. MILLION)
    100. INDIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    101. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    102. INDIA:
    103. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
    104. AUSTRALIA: PREDICTIVE GENETIC TESTING
    105. & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    106. AUSTRALIA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
    107. MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    108. AUSTRALIA: PREDICTIVE
    109. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
      1. (USD MILLION)
    110. SOUTH KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    111. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    112. SOUTH
    113. KOREA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY APPLICATION,
    114. SOUTH KOREA: PREDICTIVE GENETIC TESTING
    115. & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032 (USD MILLION)
    116. REST OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    117. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    118. REST
      1. OF ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      2. BY APPLICATION, 2023–2032 (USD MILLION)
    119. REST OF ASIA-PACIFIC:
    120. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE,
    121. REST OF THE WORLD: PREDICTIVE GENETIC
    122. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD
      1. MILLION)
    123. REST OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    124. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    125. REST
      1. OF THE WORLD: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      2. BY SETTING TYPE, 2023–2032 (USD MILLION)
    126. MIDDLE EAST: PREDICTIVE
    127. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032
      1. (USD MILLION)
    128. MIDDLE EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    129. GENOMICS MARKET, BY APPLICATION, 2023–2032 (USD MILLION)
    130. MIDDLE
    131. EAST: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING
      1. TYPE, 2023–2032 (USD MILLION)
    132. AFRICA: PREDICTIVE GENETIC TESTING
    133. & CONSUMER/WELLNESS GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    134. AFRICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET,
      1. BY APPLICATION, 2023–2032 (USD MILLION)
    135. AFRICA: PREDICTIVE GENETIC
    136. TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
      1. (USD MILLION)
    137. LATIN AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    138. GENOMICS MARKET, BY TEST TYPE, 2023–2032 (USD MILLION)
    139. LATIN
      1. AMERICA: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY
      2. APPLICATION, 2023–2032 (USD MILLION)
    140. LATIN AMERICA: PREDICTIVE
    141. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET, BY SETTING TYPE, 2023–2032
      1. (USD MILLION)
    142. LIST OF FIGURES
    143. RESEARCH PROCESS
      1. FIGURE 2
      2. MARKET STRUCTURE FOR THE GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    144. GENOMICS MARKET
    145. MARKET DYNAMICS FOR THE GLOBAL PREDICTIVE GENETIC
    146. TESTING & CONSUMER/WELLNESS GENOMICS MARKET
    147. GLOBAL PREDICTIVE
    148. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY TEST TYPE, 2020
      1. (%)
    149. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS
    150. MARKET SHARE, BY APPLICATION, 2020 (%)
    151. GLOBAL PREDICTIVE GENETIC TESTING
    152. & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY SETTING TYPE, 2020 (%)
      1. FIGURE
    153. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE,
      1. BY REGION, 2020 (%)
    154. NORTH AMERICA: PREDICTIVE GENETIC TESTING &
    155. CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
    156. EUROPE:
    157. PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION,
    158. ASIA-PACIFIC: PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS
    159. GENOMICS MARKET SHARE, BY REGION, 2020 (%)
    160. REST OF THE WORLD: PREDICTIVE
    161. GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET SHARE, BY REGION, 2020 (%)
    162. GLOBAL PREDICTIVE GENETIC TESTING & CONSUMER/WELLNESS GENOMICS MARKET:
      1. COMPANY SHARE ANALYSIS, 2020 (%)
    163. 23ANDME, INC.: FINANCIAL OVERVIEW
      1. SNAPSHOT
    164. 23ANDME, INC.: SWOT ANALYSIS
    165. MYRIAD GENETICS,
      1. INC.: FINANCIAL OVERVIEW SNAPSHOT
    166. MYRIAD GENETICS INC.: SWOT ANALYSIS
    167. F.HOFFMANN-LA ROCHE LTD.: FINANCIAL OVERVIEW SNAPSHOT
      1. FIGURE 18
      2. F.HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS
    168. ABBOTT LABORATORIES: FINANCIAL
      1. OVERVIEW SNAPSHOT
    169. ABBOTT LABORATORIES: SWOT ANALYSIS
      1. FIGURE
    170. GENESIS GENETICS: FINANCIAL OVERVIEW SNAPSHOT
    171. GENESIS GENETICS:
    172. SWOT ANALYSIS
    173. AGILENT TECHNOLOGIES: FINANCIAL OVERVIEW SNAPSHOT
    174. AGILENT TECHNOLOGIES: SWOT ANALYSIS
    175. THERMO FISHER SCIENTIFIC,
      1. INC.: FINANCIAL OVERVIEW SNAPSHOT
    176. THERMO FISHER SCIENTIFIC, INC.:
    177. SWOT ANALYSIS
    178. BUREAU GRAVIMÉTRIQUE INTERNATIONAL: FINANCIAL
      1. OVERVIEW SNAPSHOT
    179. BUREAU GRAVIMÉTRIQUE INTERNATIONAL: SWOT
      1. ANALYSIS
    180. BIO-RAD LABORATORIES INC.: FINANCIAL OVERVIEW SNAPSHOT
    181. BIO-RAD LABORATORIES INC..: SWOT ANALYSIS
    182. ILLUMINA, INC.:
      1. FINANCIAL OVERVIEW SNAPSHOT
    183. ILLUMINA, INC.: SWOT ANALYSIS
      1. FIGURE
    184. COUNSYL, INC.: FINANCIAL OVERVIEW SNAPSHOT
    185. COUNSYL, INC.: SWOT
      1. ANALYSIS
    186. ARUP LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
      1. FIGURE
    187. ARUP LABORATORIES: SWOT ANALYSIS

    Predictive Genetic Testing & Consumer/Wellness Genomics Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials